Industry Ready To Embrace Digitalization, Says IGBA
Chair Sudarshan Jain Confident Biosimilars Will Broaden Access For Chronic Diseases
IGBA chair Sudarshan Jain has indicated that "companies are undergoing the change towards digital health," in the second part of an exclusive interview with Generics Bulletin in which Jain and IGBA secretary general Suzette Kox talk about the pandemic-driven shift towards digitalization and computerization.
